Sector Gamma AS’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-102,490
Closed -$4.9M 32
2023
Q4
$4.9M Sell
102,490
-12,676
-11% -$491K 1.19% 27
2023
Q3
$4.11M Buy
115,166
+14,561
+14% +$577K 1.05% 22
2023
Q2
$4.64M Sell
100,605
-5,677
-5% -$263K 1.04% 25
2023
Q1
$4.26M Buy
106,282
+60,762
+133% +$2.61M 1.03% 27
2022
Q4
$2.11M Hold
45,520
0.48% 31
2022
Q3
$1.89M Sell
45,520
-701
-2% -$36K 0.49% 26
2022
Q2
$2.76M Hold
46,221
0.62% 31
2022
Q1
$3.36M Buy
+46,221
New +$3.22M 0.73% 32
2020
Q3
Sell
-108,734
Closed -$8.51M 33
2020
Q2
$8.51M Sell
108,734
-36,338
-25% -$2.41M 1.76% 23
2020
Q1
$6.45M Sell
145,072
-70,124
-33% -$3.64M 1.37% 26
2019
Q4
$9.19M Buy
215,196
+42,218
+24% +$1.74M 1.47% 26
2019
Q3
$7.4M Buy
172,978
+93,325
+117% +$5.07M 1.25% 29
2019
Q2
$5.06M Buy
79,653
+13,718
+21% +$873K 0.81% 33
2019
Q1
$4.57M Buy
65,935
+57,935
+724% +$3.31M 0.73% 29
2018
Q4
$348K Sell
8,000
-21,368
-73% -$1.17M 0.06% 33
2018
Q3
$2.24M Sell
29,368
-38,647
-57% -$3.14M 0.35% 29
2018
Q2
$5.23M Buy
+68,015
New +$4.39M 0.87% 26

Other funds holding RARE

Sector Gamma AS's RARE Position: Q1 2024 in Review

Sector Gamma AS sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2024, closing a stake of 102,490 shares — an estimated $4.9M sold.

Sector Gamma AS first reported a position in RARE in Q2 2018 and held it in 17 quarters. The position peaked at $9.19M in Q4 2019. 269 funds tracked by Wall St. Rank hold RARE as of Q1 2024.

  • Sector Gamma AS reported no remaining Ultragenyx Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Sector Gamma AS sold 102,490 Ultragenyx Pharmaceutical shares in Q1 2024, an estimated $4.9M.
  • Sector Gamma AS first reported a position in Ultragenyx Pharmaceutical in Q2 2018 and held it in 17 quarters.
  • Sector Gamma AS's Ultragenyx Pharmaceutical position peaked at $9.19M in Q4 2019.
  • 269 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2024.

Based on Sector Gamma AS's 13F filing for Q1 2024, filed 8 May 2024.